FERRUCCI, VERONICA
 Distribuzione geografica
Continente #
AS - Asia 2.275
EU - Europa 1.749
NA - Nord America 1.544
SA - Sud America 264
AF - Africa 77
OC - Oceania 6
Totale 5.915
Nazione #
US - Stati Uniti d'America 1.491
SG - Singapore 971
RU - Federazione Russa 679
IT - Italia 573
VN - Vietnam 466
CN - Cina 436
BR - Brasile 205
HK - Hong Kong 132
DE - Germania 120
NL - Olanda 73
IN - India 72
FR - Francia 68
GB - Regno Unito 65
UA - Ucraina 47
KR - Corea 42
JP - Giappone 41
FI - Finlandia 33
CA - Canada 31
CI - Costa d'Avorio 28
BD - Bangladesh 20
AR - Argentina 19
ZA - Sudafrica 19
ES - Italia 18
TR - Turchia 14
AT - Austria 13
IQ - Iraq 13
EC - Ecuador 12
PL - Polonia 12
SE - Svezia 12
TH - Thailandia 11
MX - Messico 10
PH - Filippine 10
PY - Paraguay 10
IE - Irlanda 9
ID - Indonesia 8
MA - Marocco 8
PK - Pakistan 6
AU - Australia 5
CO - Colombia 5
CL - Cile 4
CZ - Repubblica Ceca 4
DO - Repubblica Dominicana 4
DZ - Algeria 4
ET - Etiopia 4
IL - Israele 4
LT - Lituania 4
NP - Nepal 4
PE - Perù 4
SA - Arabia Saudita 4
TW - Taiwan 4
BE - Belgio 3
JO - Giordania 3
KE - Kenya 3
MY - Malesia 3
NO - Norvegia 3
UZ - Uzbekistan 3
VE - Venezuela 3
BY - Bielorussia 2
CH - Svizzera 2
CR - Costa Rica 2
EG - Egitto 2
HN - Honduras 2
JM - Giamaica 2
RS - Serbia 2
TN - Tunisia 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AO - Angola 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
CG - Congo 1
CV - Capo Verde 1
CY - Cipro 1
DJ - Gibuti 1
GA - Gabon 1
GE - Georgia 1
HU - Ungheria 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LV - Lettonia 1
MD - Moldavia 1
MK - Macedonia 1
ML - Mali 1
NC - Nuova Caledonia 1
NI - Nicaragua 1
PA - Panama 1
PT - Portogallo 1
SI - Slovenia 1
SN - Senegal 1
UY - Uruguay 1
Totale 5.915
Città #
Singapore 517
San Jose 275
Ashburn 181
Moscow 164
Hefei 160
Naples 153
Hong Kong 131
Ho Chi Minh City 120
Hanoi 100
Beijing 95
Chandler 76
Los Angeles 73
Napoli 65
Amsterdam 58
Santa Clara 58
Dong Ket 55
Rome 47
Lauterbourg 37
New York 37
Seoul 33
Tokyo 33
The Dalles 32
Munich 30
Boston 22
Millbury 21
São Paulo 21
Haiphong 20
Dallas 19
Milan 19
Frankfurt am Main 18
Salerno 18
Buffalo 17
Da Nang 17
Redondo Beach 17
Helsinki 16
Nuremberg 16
Lawrence 15
Council Bluffs 14
Des Moines 13
Brooklyn 12
Montreal 11
Nanjing 11
Orem 11
London 10
Princeton 10
Brasília 9
Rio de Janeiro 9
Stockholm 9
Vienna 9
Wilmington 9
Campinas 8
Chicago 8
Johannesburg 8
Phoenix 8
Rende 8
Seattle 8
Toronto 8
Turku 8
Warsaw 8
Washington 8
Battipaglia 7
Chennai 7
Houston 7
Ninh Bình 7
Quito 7
Atlanta 6
Bangkok 6
Biên Hòa 6
Bến Tre 6
Casoria 6
Denver 6
Hải Dương 6
Jiangmen 6
Asunción 5
Can Tho 5
Casavatore 5
Caserta 5
Charlotte 5
Falkenstein 5
Kochi 5
Lappeenranta 5
Lissone 5
New Delhi 5
Paris 5
Poli 5
Pozzuoli 5
Sydney 5
Thái Bình 5
Verona 5
Addis Ababa 4
Baghdad 4
Bengaluru 4
Bingen am Rhein 4
Boardman 4
Düsseldorf 4
Gatchina 4
Istanbul 4
Padova 4
Pisa 4
Pomigliano D'arco 4
Totale 3.210
Nome #
Durability of Humoral Immune Responses to SARS-CoV-2 in Citizens of Ariano Irpino (Campania, Italy): A Longitudinal Observational Study With an 11.5-Month Follow-Up 259
PRUNE is crucial for normal brain development and mutated in microcephaly with neurodevelopmental impairment 205
A Novel Human Neutralizing mAb Recognizes Delta, Gamma and Omicron Variants of SARS-CoV-2 and Can Be Used in Combination with Sotrovimab 178
Targeting ATP2B1 impairs PI3K/Akt/FOXO signaling and reduces SARS-COV-2 infection and replication 177
DDDR-32. A NEW IMMUNOMODULATORY FUNCTION OF PYRIDO-PYRIMIDINE DERIVATIVES TO IMPAIR METASTATIC GROUP 3 MEDULLOBLASTOMA IN VIVO 177
Long-chain polyphosphates impair SARS-CoV-2 infection and replication 169
International patent: PCT/EP2023/079960 - WO/2024/089190 - EP4361137; “Prune_1 inhibitors and therapeutic use thereof” 166
Loss of Detection of sgN Precedes Viral Abridged Replication in COVID-19-Affected Patients—A Target for SARS-CoV-2 Propagation 166
Novel human neutralizing mAbs specific for Spike-RBD of SARS-CoV-2 164
SARS-CoV-2 Pandemic Tracing in Italy Highlights Lineages with Mutational Burden in Growing Subsets 163
A Structurally Simple Vaccine Candidate Reduces Progression and Dissemination of Triple-Negative Breast Cancer 163
Metastatic group 3 medulloblastoma is driven by PRUNE1 targeting NME1-TGF-β-OTX2-SNAIL via PTEN inhibition. 162
Early targets of miR-34a in neuroblastoma 161
Targeting Group 3 Medulloblastoma by the Anti-PRUNE-1 and Anti-LSD1/KDM1A Epigenetic Molecules 156
Germline rare variants of lectin pathway genes predispose to asymptomatic SARS-CoV-2 infection in elderly individuals 153
A New Butyrate Releaser Exerts a Protective Action against SARS-CoV-2 Infection in Human Intestine 150
Identification of SARS-CoV-2 Proteins from Nasopharyngeal Swabs Probed by Multiple Reaction Monitoring Tandem Mass Spectrometry 149
Seroprevalence of SARS-CoV-2 Assessed by Four Chemiluminescence Immunoassays and One Immunocromatography Test for SARS-Cov-2 148
In vivo bioluminescence imaging using orthotopic xenografts towards patient's derived-xenograft Medulloblastoma models 145
MicroRNA 199b-5p delivery through stable nucleic acid lipid particles (SNALPs) in tumorigenic cell lines 143
A competitive cell-permeable peptide impairs Nme-1 (NDPK-A) and Prune-1 interaction: therapeutic applications in cancer. 142
SARS-CoV-2 Subgenomic N (sgN) Transcripts in Oro-Nasopharyngeal Swabs Correlate with the Highest Viral Load, as Evaluated by Five Different Molecular Methods 140
Natural compounds for pediatric cancer treatment 127
Glioblastoma stem cells differentiation through epigenetic modulation is driven by miR-296-5p/HMGA1/Sox2 axis 127
Heterogeneity within the PF-EPN-B ependymoma subgroup 125
AMPA receptor GluA2 subunit defects are a cause of neurodevelopmental disorders 125
Protective effects elicited by cow milk fermented with L. Paracasei CBAL74 against SARS-CoV-2 infection in human enterocytes 121
Modulation of innate immunity related genes resulting in prophylactic antimicrobial and antiviral properties 119
Pattern of Relapse and Treatment Response in WNT- Activated Medulloblastoma 118
Prune-1 drives polarization of tumor-associated macrophages (TAMs) within the lung metastatic niche in triple-negative breast cancer. 113
Epigenetics and immune cells in medulloblastoma 111
Failure of human rhombic lip differentiation underlies medulloblastoma formation 109
Italian Patent: n. 102024000005170. “Nutraceutical composition containing Propolis, Verbascum, Thymus, Polyphosphates, Potassium Sorbate and Sodium Benzoate with antiviral (SARS-CoV-2, influenza A and B, RNA herpes viruses), anti-inflammatory, antibacterial, antifungal and prebiotic activities” 106
SARS-CoV-2 uses Spike glycoprotein to control the host's anaerobic metabolism by inhibiting LDHB 106
The phenotypic and molecular spectrum of PEHO syndrome and PEHO-like disorders 104
The physiological polyphosphate as a healing biomaterial for chronic wounds: Crucial roles of its antibacterial and unique metabolic energy supplying properties 100
Italian patent: 102020000028628; “Metodo per prevedere la formazione di metastasi in pazienti tumorali” 91
Italian Patent: n. 102023000022647; “ELYSIVIR against the PI3K/Akt and TGF beta signaling cascade during SARS-CoV-2 viral infection” 87
Patent: PCT/EP2021/087512 n. 10202000003235: “Method for determining active SARS-CoV-2 infections”; “Metodo per determinare infezioni attive da sars-cov-2” 86
EP24192124.6. Composition with antiviral, antibacterial and antifungal activity. 86
Functional Genomics of PRUNE1 in Neurodevelopmental Disorders (NDDs) Tied to Medulloblastoma (MB) and Other Tumors 84
International Patent n. WO2021215617, PCT/KR2020/018989, pdpb204052; “Composition for preventing or disinfecting coronavirus infection or disease caused by coronavirus infection comprising polyphosphate” 83
Patent n. EP22154018: “Antisense compounds for the treatment of coronavirus infection” 78
PRUNE1 and NME/NDPK family proteins influence energy metabolism and signaling in cancer metastases 77
Italian Patent: n. 102023000016338; “Composition with antiviral, antibacterial and antifungal activity” 76
Totale 5.995
Categoria #
all - tutte 16.837
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.837


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202156 0 0 0 0 0 0 0 0 0 0 0 56
2021/2022324 17 1 5 1 7 3 15 12 127 14 65 57
2022/2023275 26 6 6 7 33 28 4 21 59 53 24 8
2023/2024278 9 34 43 22 26 40 12 38 10 6 29 9
2024/20251.671 54 33 48 58 80 81 164 104 153 165 609 122
2025/20263.110 312 286 334 333 464 120 470 167 335 194 90 5
Totale 5.995